Inflammation and cerebral small vessel disease: A systematic review

Abstract:
Inflammation is increasingly implicated as a risk factor for dementia, stroke, and small vessel disease (SVD). However, the underlying mechanisms and causative pathways remain unclear. We systematically reviewed the existing literature on the associations between markers of inflammation and SVD (i.e., white matter hyperintensities (WMH), lacunes, enlarged perivascular spaces (EPVS), cerebral microbleeds (CMB)) in cohorts of older people with good health, cerebrovascular disease, or cognitive impairment. Based on distinctions made in the literature, markers of inflammation were classified as systemic inflammation (e.g. C-reactive protein, interleukin-6, fibrinogen) or vascular inflammation/endothelial dysfunction (e.g. homocysteine, von Willebrand factor, Lp-PLA2). Evidence from 82 articles revealed relatively robust associations between SVD and markers of vascular inflammation, especially amongst stroke patients, suggesting that alterations to the endothelium and blood-brain barrier may be a driving force behind SVD. Conversely, cross-sectional findings on systemic inflammation were mixed, although longitudinal investigations demonstrated that elevated levels of systemic inflammatory markers at baseline predicted subsequent SVD severity and progression. Importantly, regional analysis revealed that systemic and vascular inflammation were differentially related to two distinct forms of SVD. Specifically, markers of vascular inflammation tended to be associated with SVD in areas typical of hypertensive arteriopathy (e.g., basal ganglia), while systemic inflammation appeared to be involved in CAA-related vascular damage (e.g., centrum semiovale). Nonetheless, there is insufficient data to establish whether inflammation is causal of, or secondary to, SVD. Findings have important implications on interventions, suggesting the potential utility of treatments targeting the brain endothelium and blood brain barrier to combat SVD and associated neurodegenerative diseases.
Author Listing: Audrey Low;Elijah Mak;James B. Rowe;Hugh S. Markus;John T. O’Brien
Volume: 53
Pages: None
DOI: 10.1016/j.arr.2019.100916
Language: English
Journal: Ageing Research Reviews

AGEING RESEARCH REVIEWS

AGEING RES REV

影响因子:12.5 是否综述期刊:是 是否OA:否 是否预警:不在预警名单内 发行时间:2002 ISSN:1568-1637 发刊频率:Quarterly 收录数据库:SCIE/Scopus收录 出版国家/地区:IRELAND 出版社:Elsevier Ireland Ltd

期刊介绍

As the average human life expectancy has increased, so too has the impact of ageing and age-related disease on our society. Ageing research is now the focus of thousands of laboratories that include leaders in the areas of genetics, molecular and cellular biology, biochemistry, and behaviour. Ageing Research Reviews (ARR) covers the trends in this field. It is designed to fill a large void, namely, a source for critical reviews and viewpoints on emerging findings on mechanisms of ageing and age-related disease. Rapid advances in understanding of mechanisms that control cellular proliferation, differentiation and survival are leading to new insight into the regulation of ageing. From telomerase to stem cells to energy and oxyradical metabolism, this is an exciting new era in the multidisciplinary field of ageing research. The cellular and molecular underpinnings of manipulations that extend lifespan, such as caloric restriction, are being identified and novel approaches for preventing age-related diseases are being developed. ARR publishes articles on focussed topics selected from the broad field of ageing research, with an emphasis on cellular and molecular mechanisms of the aging process and age-related diseases such as cancer, cardiovascular disease, diabetes and neurodegenerative disorders. Applications of basic ageing research to lifespan extension and disease prevention are also covered in this journal.

随着人类平均预期寿命的增加,老龄化和与年龄有关的疾病对我们社会的影响也在增加。衰老研究现在是数千个实验室的重点,其中包括遗传学、分子和细胞生物学、生物化学和行为学领域的领导者。老龄化研究评论(ARR)涵盖了这一领域的趋势。它的目的是填补一个巨大的空白,即对老龄化和与年龄有关的疾病的机制的新发现进行批判性审查和提出观点。对控制细胞增殖、分化和存活的机制的理解的快速进展导致对衰老调节的新认识。从端粒酶到干细胞再到能量和氧自由基代谢,这是衰老研究多学科领域令人兴奋的新时代。延长寿命的操作(如热量限制)的细胞和分子基础正在被确定,预防年龄相关疾病的新方法正在开发中。ARR发表的文章集中于从广泛的老龄化研究领域中选择的主题,重点是老龄化过程的细胞和分子机制以及与年龄相关的疾病,如癌症、心血管疾病、糖尿病和神经退行性疾病。这本杂志还介绍了基础老龄化研究在延长寿命和预防疾病方面的应用。

年发文量 265
国人发稿量 100
国人发文占比 37.74%
自引率 2.4%
平均录取率 约5%
平均审稿周期 平均3月
版面费 US$4820
偏重研究方向 医学-老年医学
期刊官网 http://www.journals.elsevier.com/ageing-research-reviews/
投稿链接 https://www.editorialmanager.com/ARR

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
18.92% 31.32% 0.00% 0.66%

相关指数

{{ relationActiveLabel }}
{{ item.label }}

期刊预警不是论文评价,更不是否定预警期刊发表的每项成果。《国际期刊预警名单(试行)》旨在提醒科研人员审慎选择成果发表平台、提示出版机构强化期刊质量管理。

预警期刊的识别采用定性与定量相结合的方法。通过专家咨询确立分析维度及评价指标,而后基于指标客观数据产生具体名单。

具体而言,就是通过综合评判期刊载文量、作者国际化程度、拒稿率、论文处理费(APC)、期刊超越指数、自引率、撤稿信息等,找出那些具备风险特征、具有潜在质量问题的学术期刊。最后,依据各刊数据差异,将预警级别分为高、中、低三档,风险指数依次减弱。

《国际期刊预警名单(试行)》确定原则是客观、审慎、开放。期刊分区表团队期待与科研界、学术出版机构一起,夯实科学精神,打造气正风清的学术诚信环境!真诚欢迎各界就预警名单的分析维度、使用方案、值得关切的期刊等提出建议!

预警情况 查看说明

时间 预警情况
2024年02月发布的2024版 不在预警名单中
2023年01月发布的2023版 不在预警名单中
2021年12月发布的2021版 不在预警名单中
2020年12月发布的2020版 不在预警名单中

JCR分区 WOS分区等级:Q1区

版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2021-2022年最新版)
CELL BIOLOGY Q1
GERIATRICS & GERONTOLOGY Q1

关于2019年中科院分区升级版(试行)

分区表升级版(试行)旨在解决期刊学科体系划分与学科发展以及融合趋势的不相容问题。由于学科交叉在当代科研活动的趋势愈发显著,学科体系构建容易引发争议。为了打破学科体系给期刊评价带来的桎梏,“升级版方案”首先构建了论文层级的主题体系,然后分别计算每篇论文在所属主题的影响力,最后汇总各期刊每篇论文分值,得到“期刊超越指数”,作为分区依据。

分区表升级版(试行)的优势:一是论文层级的主题体系既能体现学科交叉特点,又可以精准揭示期刊载文的多学科性;二是采用“期刊超越指数”替代影响因子指标,解决了影响因子数学性质缺陷对评价结果的干扰。整体而言,分区表升级版(试行)突破了期刊评价中学科体系构建、评价指标选择等瓶颈问题,能够更为全面地揭示学术期刊的影响力,为科研评价“去四唯”提供解决思路。相关研究成果经过国际同行的认可,已经发表在科学计量学领域国际重要期刊。

《2019年中国科学院文献情报中心期刊分区表升级版(试行)》首次将社会科学引文数据库(SSCI)期刊纳入到分区评估中。升级版分区表(试行)设置了包括自然科学和社会科学在内的18个大类学科。基础版和升级版(试行)将过渡共存三年时间,推测在此期间各大高校和科研院所仍可能会以基础版为考核参考标准。 提示:中科院分区官方微信公众号“fenqubiao”仅提供基础版数据查询,暂无升级版数据,请注意区分。

中科院分区 查看说明

版本 大类学科 小类学科 Top期刊 综述期刊
医学
1区
CELL BIOLOGY
细胞生物学
2区
GERIATRICS & GERONTOLOGY
老年医学
1区
2021年12月
基础版
医学
1区
CELL BIOLOGY
细胞生物学
2区
GERIATRICS & GERONTOLOGY
老年医学
1区
2021年12月
升级版
医学
1区
CELL BIOLOGY
细胞生物学
2区
GERIATRICS & GERONTOLOGY
老年医学
1区
2020年12月
旧的升级版
医学
1区
CELL BIOLOGY
细胞生物学
2区
GERIATRICS & GERONTOLOGY
老年医学
1区
2022年12月
最新升级版
医学
1区
CELL BIOLOGY
细胞生物学
2区
GERIATRICS & GERONTOLOGY
老年医学
1区